Researchers show that USP7 downregulation induced cellular senescence, arresting melanoma growth in vivo and proliferation in vitro in BRAF- and NRAS-mutant melanoma.
[Cell Reports]
Targeting the USP7/RRM2 Axis Drives Senescence and Sensitizes Melanoma Cells to Hdac/LSD1 Inhibitors
